TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
Research this with AI
Ask AI researches this public topic. CaptureIQ qualifies the opportunity, manages the pursuit, and prepares review-ready materials.
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75N91022F00002
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $1,435,788
- Period of performance
- Aug 5, 2022 – Feb 4, 2027
Public award description
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
Related intelligence
- Contractor: UNIVERSITY OF OKLAHOMA
- Agency: Department of Health and Human Services
- Federal market intelligence software
Related Federal Awards
- · 75N91025F00001 — BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,234,179
- · 75N92023F00001 — STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - P… · DEFINITIVE LOGIC CORPORATION · Department of Health and Human Services · $1,218,378
- · 75N91022F00004 — CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUA… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,201,554
- · 75N91026F00001 — TRIPLE NEGATIVE BREAST CANCER VACCINES · Department of Health and Human Services · $1,147,754
- · 75N91023F00001 — BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BI… · MEDIDATA SOLUTIONS, INC. · Department of Health and Human Services · $1,140,397
- · 75N91022F00003 — TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201 BASE CONTRACT TI… · Department of Health and Human Services · $982,258
Recompete monitoring
Awards approaching a documented period-of-performance end date. Related forecasts or opportunities are linked only when explicit references or strong deterministic signals match — expiration alone is not a confirmed recompete.
- Period ends
- Feb 4, 2027 (104 days)
- Evidence status
- FORECAST IDENTIFIED
- Evidence score
- 50 (deterministic, not pWin)
- Forecast evidence
- Matched forecast
Supporting evidence
- FACT: Award period end date — 2027-02-04
- FACT: Award start date — 2022-08-05
- DERIVED: Days until period end — 104
- FACT: Award recipient (incumbent on this award) — UNIVERSITY OF OKLAHOMA
- FACT: Awarding agency — Department of Health and Human Services
- FACT: Award amount (obligated/total as stored) — 1435788